NCT00129181 / 2004-001485-41: Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease |
|
|
| Completed | N/A | 30 | Europe | cabergoline, carbidopa/levodopa, DATscan and SPECT imaging | Institute for Neurodegenerative Disorders, Pfizer, GE Healthcare | Parkinson Disease, Parkinsonian Syndrome | 12/06 | 01/07 | | |
